Campbell Alliance Group collaborated with the Center to produce the study, which is informed by interviews with 45 supply chain stakeholders and other primary and secondary research sources.
The Food and Drug Administration can require a REMS program, an initiative designed to minimize risks associated with medications. The authors suggest that REMS programs affect all stakeholders in the supply chain.
The Center for Healthcare Supply Chain Research is part of the Healthcare Distribution Management Association.
Read the news release by the Center for Healthcare Supply Chain Research.
Read more coverage on supply chain:
– Amerinet, GE Healthcare/Centricity Advance Sign Agreement for Healthcare Information Services
– Access MediQuip Launches Surgical Implant Device E-Newsletter
– Patients Want to Communicate With Their Providers Online: An Opportunity for Surgery Centers
